Bayko Liisa Ann
SEC insider (Form 3/4/5 filer). CIK 0002145720. Chief Financial Officer at Kalaris Therapeutics, Inc. (KLRS). 1 reported Form 4/5 transaction since Sep 2024; latest on Jul 20, 2026. Located in BERKELEY HEIGHTS, NJ.
Companies Bayko Liisa Ann has filed insider reports for
- Kalaris Therapeutics, Inc. (KLRS): Officer, Chief Financial Officer
Bayko Liisa Ann
CIK: 0002145720
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KLRS
Kalaris Therapeutics, Inc.
Officer